Skip to content

Survey 'Living with and beyond cancer'

Cancer Survivorship Survey - Fribourg

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN89534625
Enrollment
600
Registered
2024-05-10
Start date
2024-02-28
Completion date
Unknown
Last updated
2025-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer survivors diagnosed with breast, colorectal, lung, prostate, lymphoma or myeloma Cancer

Interventions

We evaluate cancer survivors long-term problems and symptoms by applying the NCCN survivorship patient assessment complemented with additional questions on co-morbidities and medical characteristics r

Sponsors

HFR Freiburg Kantonsspital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult residents (18 years and older) treated at a site linked to the Fribourg cantonal hospital 2. Diagnosis of breast, colorectal, lung or prostate cancer 3. Diagnosis of myeloma or lymphoma 4. Cancer diagnosis one to five years ago 5. Cancer diagnosis five to ten years ago 6. Returned completed questionnaire

Exclusion criteria

Exclusion criteria: 1. Does not understand/speak French or German 2. Not treated at the HFR 3. Currently hospitalised for a cancer treatment 4. Currently under intravenous anticancer treatment

Design outcomes

Primary

MeasureTime frame
Summarize the most frequent cancer related symptoms and problems perceived by study participants, measured by questionnaire

Secondary

MeasureTime frame
Explore predictive factors related to long-term and late symptoms and/or problems measured using questionnaire and patient records

Countries

Switzerland

Contacts

Public ContactMarc Küng
marc.kueng@h-fr.ch+41 26 306 00 00

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026